Los Angeles
Primary Focus & Experience
Dr. Lu’s practice focuses on patent, trade secrets, and life sciences litigation. He has represented clients in matters involving patent infringement, U.S.-China trade secret misappropriation, biosimilars, ANDA litigation, and licensing disputes. He also represents clients in connection with proceedings before the Patent Trial and Appeal Board. His clients have included Genentech, Tris Pharma, Rosenberger, and Natera.
Recognition & Accomplishments
Dr. Lu has been on the editorial advisory board for Law360 Life Science publications and was named to Benchmark Litigation’s “40 and Under Hot List,” which honors the achievements of the nation’s most accomplished litigators under 40. He was also named to the Southern California Rising Stars list by Super Lawyers.
Dr. Lu has authored a number of publications, including: “Thryv: opposing policies in the Supreme Court,” World Intellectual Property Review (June 5, 2020); “The Growth of Online Universities: How to Solve the Accreditation Dilemma, Protect Students, and Expand Access to Higher Education,” a chapter in “Education and Social Media: Toward a Digital Future,” MIT Press (2016); “Senate Gridlock Causes En Banc Uncertainty,” and “Intellectual Property Special Report,” The Recorder (July 15, 2013); and “Promotion and Market Share in the Proton Pump Inhibitor Market: A Case Study,” Journal of Pharmaceutical Marketing & Management, Volume 17, Issue 3, 39-59 (2007).
Dr. Lu is the chair of the board of directors for Asian Pacific American Dispute Resolution Center (APADRC), a nonprofit organization. He was also a Fellow of the Leadership Council on Legal Diversity.
Prior to private practice, Dr. Lu was a law clerk to the Honorable William Alsup of the U.S. District Court for the Northern District of California.
Dr. Lu received his J.D. from Yale Law School, where he was Notes Editor of the Yale Law Journal and Executive Editor of the Yale Journal of Law & Technology. While in law school, he was an extern for the Honorable John T. Noonan of the U.S. Court of Appeals for the Ninth Circuit, and an intern for the U.S. Attorney’s Office for the District of Connecticut.
Prior to law school, Dr. Lu earned his Doctor of Pharmacy, with highest distinction, from the University of North Carolina, and worked in pharmaceutical marketing.
Dr. Lu is conversant in Mandarin Chinese.
Chicago
Alejandra advises sponsors, lenders and agents on all aspects of a project, from drafting, negotiation and review of traditional project documents, including EPCs, O&Ms and MSAs through procuring construction financing and term loans for the operation and maintenance of the asset. Her tax equity practice includes drafting and negotiating the traditional tax equity partnerships (for PFlip and TFlip structures) documentation, tax credit transfer agreements and advising construction and back leverage lenders in connection with tax equity portfolios.
Alejandra’s experience spans a range of power generating technologies and projects, from solar, wind and hydro to biofuel, carbon capture, oil and gas and LNG projects. She has also led financings for major international infrastructure projects such as airports, water treatment, power generation and toll roads.
A native Spanish speaker, Alejandra has worked extensively across Latin America, including Mexico, Chile, Uruguay, the Dominican Republic and Colombia.
Washington, D.C.
Emily routinely handles all aspects of civil and class action litigation, from early motions practice to trial before a jury or arbitration panel. Her extensive litigation practice concentrates on antitrust and competition law, and she has represented plaintiffs, defendants, and third parties in high-stakes matters.
In addition to her litigation practice, Emily also advises clients on a spectrum of critical antitrust and competition matters, spanning government investigations, merger clearance, and strategic counseling. She adeptly navigates clients through the intricacies of regulatory inquiries and enforcement actions, specifically from the FTC and DOJ. She represents clients across a diverse range of industries, including technology, healthcare and life sciences, automotive, oil & gas, and professional membership organizations.
Notably, Emily has developed a focus on issues at the intersection of antitrust and intellectual property, with a particular emphasis on standards-essential patents (SEPs) subject to a commitment to license on fair, reasonable, and nondiscriminatory terms (FRAND). In addition to representing clients in licensing negotiations, litigation matters, and government outreach with respect to SEPs and FRAND, she has authored extensive thought leadership on this topic.
Prior to law school, Emily worked as a research assistant and project coordinator at the Brookings Institution in Washington, D.C.
Düsseldorf
Prior to joining Orrick, Odey served as a research assistant to a distinguished chair focusing on European law, where he authored several academic papers. Throughout his doctoral studies, he delved deeply into the intricate realms of European, international, and data protection law.
Additionally, Odey contributed to significant legal opinions and gained practical experience by supporting the representation of the German Federal Government in pivotal cases before the Federal Constitutional Court, including the proceedings on the European Patent Convention, CETA and the EU-Singapore Free Trade Agreement.
Before starting his legal practice, he also worked as a research assistant for an international UK-headquartered law firm.
Los Angeles
Los Angeles
Lauren has represented clients in connection with a broad spectrum of technologies, including small molecules, biologics, DNA sequencing, gene editing, recombinant DNA technology, and medical devices. She brings experience in litigation under the Hatch-Waxman Act and the Biologics Price Competition Innovation Act (BPCIA).
Lauren was recognized by Law360’s Rising Stars as “one of the top intellectual property attorneys under the age of 40” in 2019. She was also named to Benchmark Litigation’s “40 and Under Hot List,” which honors the achievements of the nation’s most accomplished litigators under 40.
Boston
As a trial lawyer, Mark excels at handling accelerated, complex cases. For example, as lead counsel for New Balance, Mark won a swift six-month International Trade Commission (ITC) investigation concerning claims of trade dress infringement. And, as lead plaintiff counsel for Explorica in a trademark case, he won a jury verdict just ten weeks after filing the complaint. During that short span, the parties engaged in complete discovery, including taking and defending numerous fact and expert depositions. Clients routinely ask him to take over matters at the close of discovery, prior to trial, or on remand, which presents unique challenges and time constraints.
He is also skilled at explaining complex concepts and technology to judges and juries in a persuasive, intelligible style. For example, in the high-profile Supreme Court case ABC v. Aereo, he led the trial and appellate team’s presentation of the key technology. That presentation was the basis of the trial court’s denial of a preliminary injunction, and the Second Circuit’s affirmance of that decision.
Mark draws upon his litigation experience to help clients anticipate and avoid legal issues related to new technologies and brands. Mark has advised numerous technology and media companies on the creation, use, and delivery of content and helped clients assess whether their products will withstand investor and competitor scrutiny. He also has significant experience advising on branding and re-branding projects, including private brand or store brand clearance and risk assessments.
Mark’s exceptional record has earned him praise as a problem solver from client and peer surveys. Most recently, Chambers USA described him as "extremely skilled and effective." World Trademark Review 1000 has called him “intelligent, thoughtful and client-oriented” and “incredibly impressive.” The Legal 500 has described him as a “smart, creative” trial lawyer who “anticipates everything.” And in 2016, IP Law360 named two of his cases among the top ten trademark decisions of the year.
Washington, D.C.
Washington, D.C.
Josh is a Global and U.S. Chambers-ranked Section 337 advocate before the U.S. International Trade Commission. Legal 500 lists Josh among the 17 Leading Partners before the ITC categorized as the strongest partners in their field, leading on market-leading deals. He is also a D.C. Super Lawyer in IP litigation, and Patexia has consistently ranked him as a “most-active” and "best performing" ITC practitioner for each of the past five years.
Josh’s practice centers on blocking and defending imports before the ITC. He regularly serves as lead ITC counsel for domestic and international companies – particularly those from Asia and Europe – in Section 337 investigations. Over the past decade, Josh has been to ITC trial for over a dozen Fortune Global 500 companies. Clients and peers alike praise Josh as “an ITC guru” as well as “…a strong ITC litigator and also a please person to work with or against.” He focuses on matters involving brand protection, patent, trademark, and copyright infringement, international trade secret theft and unfair competition claims.
In addition to the ITC, Josh is active before the U.S. Patent and Trademark Office, U.S. District Courts and the Federal Circuit. Recent patent-validity challenge highlights at the USPTO’s Patent Trial and Appeal Board include a complete five-patent Inter Partes Review defense victory, as well as a two-patent invalidating IPR win, affirmed at the Federal Circuit, as well as a key patent defense through Ex Parte Reexamination. Josh’s most recent District Court win was a jury verdict in favor of his client ScentAir in Delaware. Abroad, China has featured prominently among recent global forums for Josh’s matters, as well as Canada and Germany.
Josh’s IP portfolio strategies are catered to meeting enforcement challenges. His clients include companies ranging from startups to multinationals in electronics, consumer products, telecommunications, mechanical and medical devices, and biochemicals.
A founding member of the Advisory Council to Georgetown's Institute for Technology Law & Policy, Josh also has been a fellow in the Hispanic National Bar Association’s IP Law Institute. He was a founding editor of the ITC Trial Lawyers Association’s 337 Reporter Round-Up.
Josh served in the U.S. Marine Corps as a field artillery captain. He was deployed to the Persian Gulf and awarded the Defense Meritorious Service Medal. As part of his pro bono service, Josh advocates for fellow veterans with the “Lawyers Serving Warriors” team of the National Veterans Legal Services Program.
Prior to joining Orrick, Josh co-led a global law firm’s ITC Section 337 litigation practice.
New York
Jordan has represented clients in an array of intellectual property disputes, including those involving patent infringement, trade secret misappropriation, and trademark infringement. He has also represented clients in disputes involving intellectual property licenses. Jordan has practiced in various federal district courts, as well as before the Federal Circuit, the Patent Trial and Appeal Board, and the International Trade Commission, achieving successful outcomes for both plaintiffs and defendants at jury and bench trials alike.
In addition to his work in the life sciences sector, Jordan has substantial experience in the technology sector. He has litigated intellectual property disputes related to energy storage, OLED displays, base station antennas, fiber optics, and video game rendering. Jordan has also counseled clients on intellectual property licensing, patent prosecution and portfolio management, and intellectual property and information technology issues arising in commercial transactions.
Jordan maintains a robust pro bono practice and is currently involved in litigation concerning reproductive rights. He previously litigated claims of racial discrimination by police, which resulted in criminal justice reform within the police department. Jordan also helped exonerate a pro bono client, who had spent over 16 years in prison for a crime that he did not commit.
Los Angeles
David has achieved extraordinary trial outcomes for both plaintiffs and defendants, including a $302 million verdict for breach of a research and license agreement covering foundational biotechnology, as well as defeating a $217 million damages claim in a patent dispute where liability had already been established in an earlier trial handled by a different law firm. David also negotiates complex intellectual property license agreements involving cutting-edge technologies and creative financial structures, frequently working on behalf of leading academic institutions.
Orange County
Lauren supports and leads projects aimed at optimizing client service delivery and increasing efficiencies. Based in Orange County, she collaborates across offices, practice groups, and departments to streamline legal processes through the integration of technology, automation, and data-driven solutions. Her responsibilities include developing best practices, supporting the firm’s data strategy, and spearheading the rollout and adoption of legal technology within the business units.
Prior to moving into this role, Lauren was a Senior Associate in Orrick’s Securities Litigation group, where she represented and advocated for clients in complex litigation, government regulatory matters, and internal investigations. These experiences have made Lauren well-suited to design and improve client-facing solutions, create tailored workflows, and enhance collaboration with clients and third parties. Her familiarity with legal technology and enthusiasm for leveraging AI in legal services align perfectly with Orrick’s commitment to innovation.
Her diverse legal experience, combined with her proactive and innovative approach, positions her as a key player in Orrick’s ongoing efforts to lead the industry in delivering high-quality, efficient legal services.
San Francisco; Los Angeles
San Francisco; Los Angeles
David assists major financial institutions and alternative lenders in effectively assessing legal risks in complex secured and unsecured commercial finance transactions. He advises on bilateral, club and syndicated financings for acquisitions, dividend recapitalizations, construction and refinancings. He has extensive experience in financings in the casino gaming (commercial and tribal) and technology sectors.
New York
Ken represents issuers, underwriters and selling security holders on public and private offerings of debt and equity securities and liability management transactions, such as exchange offers, tender offers, and consent solicitations. He also guides businesses through all stages of organization and development by advising on ’34 Act and indenture reporting compliance, corporate governance and related regulatory matters, venture capital and growth equity financings, and corporate and securities law matters arising in connection with merger and acquisition transactions and corporate restructurings and reorganizations. Ken has served as counsel to companies in a variety of industries, including information technologies and services, life sciences and biotechnology, fintech, infrastructure, advertising, telecommunications, clean technology, financial services, and consumer products.
Before his law career, Ken managed his own company, consulting for technology startups, financial services firms, and advertising agencies on web-based initiatives.